Azithromycin 500mg IV Reconstitution, Dilution, and Administration
Reconstitute azithromycin 500mg vial with exactly 4.8 mL of Sterile Water for Injection to achieve 100 mg/mL concentration, then dilute to either 1 mg/mL (500 mL total) or 2 mg/mL (250 mL total) using compatible IV fluids, and infuse over a minimum of 60 minutes—never as a bolus or intramuscular injection. 1
Reconstitution Steps
- Add 4.8 mL of Sterile Water for Injection to the 500 mg vial using a standard 5 mL non-automated syringe (the vial is under vacuum, so precise measurement is critical)
- Shake until completely dissolved
- Each mL of reconstituted solution = 100 mg azithromycin
- Reconstituted solution stable for 24 hours at <30°C (86°F) 1
- Inspect visually for particulate matter—discard if present 1
Dilution Protocol
Transfer the entire 5 mL of reconstituted solution (500 mg) into one of these compatible diluents 1:
For 1 mg/mL concentration (preferred):
- Add to 500 mL of diluent
- Infuse over 3 hours (or minimum 60 minutes)
For 2 mg/mL concentration:
- Add to 250 mL of diluent
- Infuse over 1 hour minimum
Compatible Diluents 1:
- Normal Saline (0.9% NaCl)
- 5% Dextrose in Water
- Lactated Ringer's Solution
- 1/2 Normal Saline (0.45% NaCl)
- 5% Dextrose in 1/2 Normal Saline with 20 mEq KCl
- 5% Dextrose in Lactated Ringer's
- Other listed compatible solutions
Administration Requirements
Critical infusion parameters:
- Minimum infusion time: 60 minutes 1
- Maximum concentration: 2 mg/mL—concentrations above this cause universal local IV site reactions 1
- Never administer as bolus or IM injection 1
- Use dedicated IV line—do not mix with other medications or infuse simultaneously 1
Stability After Dilution
Critical Safety Considerations
Local IV site reactions:
- Incidence and severity are concentration-dependent 1
- All subjects receiving >2 mg/mL experienced reactions 1
- The 1 mg/mL and 2 mg/mL concentrations show equivalent safety profiles when infused appropriately 1
Special populations requiring caution:
- Hepatic impairment: Exercise caution as azithromycin is primarily hepatically eliminated 1
- Severe renal impairment (GFR <10 mL/min): Use with caution; AUC increases 35% 1
- Prolonged QTc: Contraindicated if QTc >450 ms (men) or >470 ms (women) 2
Practical Note on Volume Reduction
While FDA labeling specifies 1-2 mg/mL concentrations, one retrospective ICU study found that concentrations up to 5 mg/mL (100 mL total volume) infused over 2 hours via infusion pump caused no peripheral phlebitis 3. However, this contradicts FDA data showing universal reactions above 2 mg/mL 1, so concentrations above 2 mg/mL should be avoided in standard practice unless absolutely necessary for fluid restriction in critical care settings with close monitoring.